The Australian & New Zealand journal of obstetrics & gynaecology
-
Aust N Z J Obstet Gynaecol · Feb 2010
An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section.
The use of oxytocin to prevent postpartum haemorrhage at elective caesarean section is largely based on evidence derived from vaginal births. Overseas studies indicate wide variation in practice with regard to specific doses of oxytocin administered at caesarean section. No such surveys have been undertaken in Australia or New Zealand. ⋯ There are wide variations in the usage of oxytocin at elective caesarean section in Australia and New Zealand, most likely due to a lack of high level evidence to guide practice. Appropriately designed clinical trials are needed to provide evidence to support future practice.
-
Aust N Z J Obstet Gynaecol · Feb 2010
Randomized Controlled TrialIntra-uterine bupivacaine and levobupivacaine.
The study aimed to compare the effect of intrauterine bupivacaine and levobupivacaine with placebo in reducing the post-procedure discomfort owing to pain caused by suction endometrial sampling. ⋯ Intrauterine levobupivacaine or bupivacaine is effective in decreasing the pain associated with the endometrial biopsy and curettage under propofol sedation.
-
Aust N Z J Obstet Gynaecol · Feb 2010
Randomized Controlled TrialUse of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
The purpose of this prospective, randomised, double-blind, placebo-controlled study was to assess the effects of a 5-IU oxytocin bolus and placebo infusion versus a 5-IU oxytocin bolus and 30 IU infusion on the control of blood loss at elective lower segment caesarean section (C/S). ⋯ An additional oxytocin infusion after 5 IU oxytocin bolus infusion at elective C/S may reduce blood loss and required blood transfusion.